Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112686244 | 11268624 | 4 | F | 20140815 | 20160802 | 20150714 | 20160912 | PER | US-JNJFOC-20150704776 | JANSSEN | 70.03 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112686244 | 11268624 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 112686244 | 11268624 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 112686244 | 11268624 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | UNKNOWN | 202439 | 20 | MG | TABLET | |||||
| 112686244 | 11268624 | 4 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 0 | 5 | MG | UNSPECIFIED | |||||||
| 112686244 | 11268624 | 5 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 0 | 5 | MG | UNSPECIFIED | |||||||
| 112686244 | 11268624 | 6 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | 81 | MG | UNSPECIFIED | |||||||
| 112686244 | 11268624 | 7 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 112686244 | 11268624 | 8 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 112686244 | 11268624 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | UNSPECIFIED | |||||||||||
| 112686244 | 11268624 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 112686244 | 11268624 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112686244 | 11268624 | 1 | Thrombosis prophylaxis |
| 112686244 | 11268624 | 2 | Cerebrovascular accident prophylaxis |
| 112686244 | 11268624 | 3 | Atrial fibrillation |
| 112686244 | 11268624 | 4 | Anticoagulant therapy |
| 112686244 | 11268624 | 5 | Atrial fibrillation |
| 112686244 | 11268624 | 6 | Anticoagulant therapy |
| 112686244 | 11268624 | 7 | Product used for unknown indication |
| 112686244 | 11268624 | 8 | Product used for unknown indication |
| 112686244 | 11268624 | 9 | Product used for unknown indication |
| 112686244 | 11268624 | 10 | Product used for unknown indication |
| 112686244 | 11268624 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112686244 | 11268624 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112686244 | 11268624 | Internal haemorrhage | |
| 112686244 | 11268624 | Melaena |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112686244 | 11268624 | 1 | 20140811 | 20141120 | 0 | |
| 112686244 | 11268624 | 2 | 20140811 | 20141120 | 0 | |
| 112686244 | 11268624 | 3 | 20140811 | 20141120 | 0 | |
| 112686244 | 11268624 | 4 | 2014 | 0 | ||
| 112686244 | 11268624 | 5 | 2014 | 0 |